CTI BIOPHARMA CORP (CTIC)
Institutional ownership reported to the SEC as of Q2 2023, across 19 quarters.
3
Reporting holders
$474.3K
Reported value
0.0%
Held as options
-113
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | $389.3K | 92,700 | 0.00% | 3q | HELD |
| Legal & General Group Plc | $84.9K | 9,340 | 0.00% | 5q | -78.5%-$310.7K |
| SIMPLEX TRADING, LLC | $11 | options only | 0.00% | 10q | OPTIONS |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 3 | $474.3K | 102,040 | 0 | 0 | 1 | 0.0% |
| Q1 2023 | 116 | $444.5M | 104,310,330 | 19 | 47 | 26 | 1.5% |
| Q4 2022 | 119 | $542.2M | 95,282,511 | 29 | 37 | 32 | 2.0% |
| Q3 2022 | 127 | $575.1M | 98,967,136 | 29 | 46 | 39 | 2.3% |
| Q2 2022 | 112 | $519.9M | 88,522,470 | 51 | 34 | 19 | 1.9% |
| Q1 2022 | 83 | $350.6M | 59,622,111 | 30 | 23 | 15 | 1.6% |
| Q4 2021 | 56 | $122.4M | 48,414,047 | 12 | 16 | 15 | 1.9% |
| Q3 2021 | 53 | $160.4M | 54,117,041 | 12 | 11 | 13 | 0.4% |
| Q2 2021 | 46 | $134.9M | 53,275,563 | 4 | 17 | 12 | 1.3% |
| Q1 2021 | 51 | $127.1M | 43,335,796 | 11 | 20 | 10 | 0.8% |
| Q4 2020 | 56 | $142.4M | 43,731,547 | 27 | 8 | 7 | 1.1% |
| Q3 2020 | 33 | $85.8M | 39,582,770 | 7 | 8 | 6 | 0.8% |
| Q2 2020 | 35 | $40.0M | 34,460,519 | 7 | 5 | 8 | 0.1% |
| Q1 2020 | 32 | $33.7M | 36,631,744 | 5 | 11 | 5 | 0.1% |
| Q4 2019 | 34 | $40.1M | 25,293,805 | 7 | 8 | 6 | 0.5% |
| Q3 2019 | 36 | $21.1M | 25,176,181 | 1 | 6 | 13 | 0.2% |
| Q2 2019 | 49 | $24.0M | 27,266,240 | 9 | 7 | 17 | 2.4% |
| Q1 2019 | 60 | $29.9M | 30,584,688 | 8 | 9 | 20 | 0.6% |
| Q4 2018 | 65 | $26.1M | 35,541,668 | 4 | 2 | 0 | 0.1% |